Drug intelligence / Profile preview

Respiratory Syncytial Virus Fusion protein subunit

Development stage
Unknown
Lead developer
Pfizer
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

The Respiratory Syncytial Virus (RSV) Fusion (F) protein subunit is a critical viral surface glycoprotein that mediates the fusion of the viral envelope with the host cell membrane, a crucial step for viral entry and infection. It exists in two main conformations: a metastable pre-fusion (PreF) state and a stable post-fusion state. The PreF conformation is particularly important as it exposes key neutralizing epitopes, making it a primary target for the development of vaccines and antiviral therapies against RSV. By targeting the F protein, therapeutic interventions aim to inhibit viral entry and replication, thereby preventing or reducing the severity of RSV infections. Approved vaccines, such as Abrysvo (Pfizer) and Arexvy (GSK), utilize the prefusion F protein to induce protective immune responses.

Other names
RSV Fusion glycoproteinRSV F glycoprotein
02

Targets

RSV F (Respiratory syncytial virus fusion protein)

Beyond the preview

Go deeper on Respiratory Syncytial Virus Fusion protein subunit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory Syncytial Virus Fusion protein subunit.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call